Cargando…

Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy

BACKGROUND: LncRNA AK044604 (regulator of insulin sensitivity and autophagy, Risa) and autophagy-related factors Sirt1 and GSK3β play important roles in diabetic nephropathy (DN). In this study, we sought to explore the effect of Risa on Sirt1/GSK3β-induced podocyte injury. METHODS: Diabetic db/db m...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Pei-Pei, Liu, Dong-Wei, Zhou, Si-Jie, Chen, Hang, Wu, Xian-Ming, Liu, Zhang-Suo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134699/
https://www.ncbi.nlm.nih.gov/pubmed/35614465
http://dx.doi.org/10.1186/s40779-022-00385-0
_version_ 1784713815100751872
author Su, Pei-Pei
Liu, Dong-Wei
Zhou, Si-Jie
Chen, Hang
Wu, Xian-Ming
Liu, Zhang-Suo
author_facet Su, Pei-Pei
Liu, Dong-Wei
Zhou, Si-Jie
Chen, Hang
Wu, Xian-Ming
Liu, Zhang-Suo
author_sort Su, Pei-Pei
collection PubMed
description BACKGROUND: LncRNA AK044604 (regulator of insulin sensitivity and autophagy, Risa) and autophagy-related factors Sirt1 and GSK3β play important roles in diabetic nephropathy (DN). In this study, we sought to explore the effect of Risa on Sirt1/GSK3β-induced podocyte injury. METHODS: Diabetic db/db mice received Risa-inhibition adeno-associated virus (AAV) via tail vein injection, and intraperitoneal injection of lithium chloride (LiCl). Blood, urine, and kidney tissue samples were collected and analyzed at different time points. Immortalized mouse podocyte cells (MPCs) were cultured and treated with Risa-inhibition lentivirus (LV), EX-527, and LiCl. MPCs were collected under different stimulations as noted. The effects of Risa on podocyte autophagy were examined by qRT-PCR, Western blotting analysis, transmission electron microscopy, Periodic Acid-Schiff staining, and immunofluorescence staining. RESULTS: Risa and activated GSK3β were overexpressed, but Sirt1 was downregulated in DN mice and high glucose-treated MPCs (P < 0.001, db/m vs. db/db, NG or HM vs. HG), which was correlated with poor prognosis. Risa overexpression attenuated Sirt1-mediated downstream autophagy levels and aggravated podocyte injury by inhibiting the expression of Sirt1 (P < 0.001, db/m vs. db/db, NG or HM vs. HG). In contrast, Risa suppression enhanced Sirt1-induced autophagy and attenuated podocyte injury, which could be abrogated by EX-527 (P < 0.001, db/db + Risa-AAV vs. db/db, HG + Risa-LV vs. HG). Furthermore, LiCl treatment could restore GSK3β-mediated autophagy of podocytes (P < 0.001, db/db + LiCl vs. db/db, HG + LiCl vs. HG), suggesting that Risa overexpression aggravated podocyte injury by decreasing autophagy. CONCLUSION: Risa could inhibit autophagy by regulating the Sirt1/GSK3β axis, thereby aggravating podocyte injury in DN. Risa may serve as a therapeutic target for the treatment of DN. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40779-022-00385-0.
format Online
Article
Text
id pubmed-9134699
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91346992022-05-27 Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy Su, Pei-Pei Liu, Dong-Wei Zhou, Si-Jie Chen, Hang Wu, Xian-Ming Liu, Zhang-Suo Mil Med Res Research BACKGROUND: LncRNA AK044604 (regulator of insulin sensitivity and autophagy, Risa) and autophagy-related factors Sirt1 and GSK3β play important roles in diabetic nephropathy (DN). In this study, we sought to explore the effect of Risa on Sirt1/GSK3β-induced podocyte injury. METHODS: Diabetic db/db mice received Risa-inhibition adeno-associated virus (AAV) via tail vein injection, and intraperitoneal injection of lithium chloride (LiCl). Blood, urine, and kidney tissue samples were collected and analyzed at different time points. Immortalized mouse podocyte cells (MPCs) were cultured and treated with Risa-inhibition lentivirus (LV), EX-527, and LiCl. MPCs were collected under different stimulations as noted. The effects of Risa on podocyte autophagy were examined by qRT-PCR, Western blotting analysis, transmission electron microscopy, Periodic Acid-Schiff staining, and immunofluorescence staining. RESULTS: Risa and activated GSK3β were overexpressed, but Sirt1 was downregulated in DN mice and high glucose-treated MPCs (P < 0.001, db/m vs. db/db, NG or HM vs. HG), which was correlated with poor prognosis. Risa overexpression attenuated Sirt1-mediated downstream autophagy levels and aggravated podocyte injury by inhibiting the expression of Sirt1 (P < 0.001, db/m vs. db/db, NG or HM vs. HG). In contrast, Risa suppression enhanced Sirt1-induced autophagy and attenuated podocyte injury, which could be abrogated by EX-527 (P < 0.001, db/db + Risa-AAV vs. db/db, HG + Risa-LV vs. HG). Furthermore, LiCl treatment could restore GSK3β-mediated autophagy of podocytes (P < 0.001, db/db + LiCl vs. db/db, HG + LiCl vs. HG), suggesting that Risa overexpression aggravated podocyte injury by decreasing autophagy. CONCLUSION: Risa could inhibit autophagy by regulating the Sirt1/GSK3β axis, thereby aggravating podocyte injury in DN. Risa may serve as a therapeutic target for the treatment of DN. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40779-022-00385-0. BioMed Central 2022-05-26 /pmc/articles/PMC9134699/ /pubmed/35614465 http://dx.doi.org/10.1186/s40779-022-00385-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Su, Pei-Pei
Liu, Dong-Wei
Zhou, Si-Jie
Chen, Hang
Wu, Xian-Ming
Liu, Zhang-Suo
Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy
title Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy
title_full Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy
title_fullStr Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy
title_full_unstemmed Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy
title_short Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy
title_sort down-regulation of risa improves podocyte injury by enhancing autophagy in diabetic nephropathy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134699/
https://www.ncbi.nlm.nih.gov/pubmed/35614465
http://dx.doi.org/10.1186/s40779-022-00385-0
work_keys_str_mv AT supeipei downregulationofrisaimprovespodocyteinjurybyenhancingautophagyindiabeticnephropathy
AT liudongwei downregulationofrisaimprovespodocyteinjurybyenhancingautophagyindiabeticnephropathy
AT zhousijie downregulationofrisaimprovespodocyteinjurybyenhancingautophagyindiabeticnephropathy
AT chenhang downregulationofrisaimprovespodocyteinjurybyenhancingautophagyindiabeticnephropathy
AT wuxianming downregulationofrisaimprovespodocyteinjurybyenhancingautophagyindiabeticnephropathy
AT liuzhangsuo downregulationofrisaimprovespodocyteinjurybyenhancingautophagyindiabeticnephropathy